Dr. Adam R. Abate's lab focuses on developing innovative diagnostic technologies to improve the identification of infectious diseases and study rare cell populations involved in conditions like multiple sclerosis. The lab combines next-generation sequencing with unique methods to enhance pathogen detection and offers insights into complex cellular mechanisms by analyzing specific cell types from samples. The goal is to provide healthcare professionals with more accurate tools for diagnosing infections and understanding related diseases.

Dr. Nadav Ahituv's lab focuses on using adipose tissues (body fat) to develop innovative cancer therapies. By bioengineering fat cells to mimic brown adipose tissue, which is more effective in utilizing glucose and fat, they aim to suppress tumor growth. The lab's research is groundbreaking because it explores using engineered adipocytes (fat cells) as a form of cellular therapy to combat various types of cancer.

Dr. Danica Galonic Fujimori's lab focuses on understanding how certain bacteria develop resistance to antibiotics through modifications to their ribosomes. This research is important because it helps us combat the growing problem of antibiotic resistance, which affects public health and treatment options. The lab uses advanced techniques to study the enzymes involved in this process and aims to uncover new strategies to tackle bacterial infections.

Dr. Kathleen Giacomini's lab at UCSF focuses on studying membrane transporters, which are crucial for moving drugs, nutrients, and other substances across cell membranes, especially in the brain. The lab seeks to understand how these transporters work in the blood-brain barrier, a critical site that regulates what enters the brain. By using cutting-edge methods like structural biology and computational modeling, the team aims to identify potential new treatments and improve our understanding of drug delivery in the brain.

Dr. Ryan D. Hernandez's lab focuses on human genetics and evolution, particularly how genetic ancestry affects complex traits across diverse populations. The lab utilizes an extensive dataset from the Trans-Omics for Precision Medicine project to investigate genetic variations and their implications for human health. Their research integrates evolutionary theory with modern computational methods to address pressing questions related to health disparities and precision medicine.

Dr. Hyunil Jo's lab at UCSF focuses on researching liver fibrosis, a severe condition that leads to liver failure. The lab is working on developing new drugs that target an enzyme called acid ceramidase, which has been shown to play a significant role in liver fibrosis. By creating potent inhibitors of this enzyme, they hope to provide effective treatments for patients suffering from chronic liver diseases, where current options are limited.

Dr. Aashish Manglik's lab at UCSF focuses on understanding how our sense of smell works. They study specific proteins called odorant receptors, which allow us to detect various smells. By analyzing the structure and function of these receptors, the lab aims to uncover the mechanisms of smell perception, which could lead to new treatments for smell-related disorders.

Professor Thomas E Ferrin's lab focuses on creating advanced software tools for visualizing and analyzing complex molecular structures. Their primary program, ChimeraX, allows researchers to interact with detailed biological data, helping to uncover insights about diseases and drug targets. The lab aims to make these powerful tools accessible to scientists worldwide, enhancing our understanding of molecular biology and contributing to improvements in biomedical research.

Dr. Tanja Kortemme's lab at UCSF focuses on designing and engineering proteins to enhance their biological functions and correct errors in cellular processes. They use computational methods to create new proteins that can respond to signals within cells and investigate how existing proteins operate within cellular networks. This research not only aims to improve our understanding of biology but also to develop new strategies for therapeutic applications in medicine and biotechnology.

Dr. Radojka Savic's lab at UCSF focuses on improving tuberculosis (TB) treatment by developing new drug regimens and diagnostics. The lab aims to enhance the accuracy of TB diagnosis through innovative blood tests that measure cell-free RNA, and to optimize treatment strategies using advanced modeling and animal studies. By collaborating with a multidisciplinary team, they seek to tackle the pressing global health challenge of TB, aiming for shorter and more effective treatment options.

Dr. James Solomon Fraser's lab at UCSF focuses on understanding the diverse structural forms that proteins can take, especially how these forms change in response to drugs or mutations. They develop advanced methods to visualize and manipulate these structures, aiming to improve drug design and create new treatments to fight antibiotic resistance. The lab combines experimental techniques in crystallography and cryo-electron microscopy with computational modeling to enhance our understanding of protein dynamics.

Dr. James A. Wells' lab focuses on understanding the proteins on the surface of cells, known as the surfaceome. These proteins are crucial for how cells communicate and respond to their environment. By developing innovative technologies, his team aims to analyze small populations of cells at high resolution, particularly in the context of cancer and neurodegenerative diseases. Their goal is to identify new biomarkers and drug targets, as well as to create specific antibodies that can better modulate cell functions.

Dr. Wendell Lim's lab at UCSF focuses on engineering immune cells to improve their ability to infiltrate and effectively treat solid tumors that typically repel immune responses. By developing synthetic circuits that enhance T cell trafficking towards these tumors, the team aims to increase the effectiveness of CAR T cell therapies, particularly against immune-excluded tumors like pancreatic cancer. This innovative approach to immunotherapy has the potential to revolutionize cancer treatment by making even hard-to-treat tumors vulnerable to immune attack.

Dr. Kathryn A. Phillips' lab focuses on understanding how emerging genomic tests, like cell-free DNA tests and polygenic risk scores, can be integrated into healthcare policies and practices. The lab investigates payer coverage decisions to determine the economic value of these tests in both disease management and screening scenarios. They aim to ensure that advancements in genomic medicine are accessible and beneficial for all patients, addressing issues like equity and disparity in healthcare access.

Dr. Holly A. Ingraham's lab at UCSF focuses on understanding how the brain communicates with organs like the bladder and bones to maintain health, especially as we age. The team investigates neural circuits that influence urinary control and the relationship between the brain and bone health. Additionally, they explore the mechanisms behind abdominal pain related to digestive issues. This research aims to develop new strategies to improve health and quality of life for aging populations, particularly women.

Professor Brian K. Shoichet's lab focuses on creating new methods for discovering potential drugs by using computational and experimental approaches. They especially aim to understand how different molecules interact with biological targets, like proteins, to influence health and disease. The lab works on large libraries of compounds to test how changes in these libraries affect drug discovery outcomes, aiming to find new insights into drug interactions and delivery methods.

Dr. Zev Jordan Gartner's lab at UCSF focuses on understanding how the tiny finger-like structures in the intestine, called villi, are formed and repaired. This is important because healthy villi are essential for absorbing nutrients, and their dysfunction can lead to serious digestive diseases. The lab combines advanced imaging techniques and mouse genetics to study the forces and signals that drive villus growth and branching. Their research could lead to new therapies for gastrointestinal diseases and strategies for tissue regeneration.

Dr. William Degrado's lab at UCSF explores how proteins work by studying their structures and functions. They focus on viral proteins, particularly those found in influenza and coronaviruses, to design new drugs that can block these viruses, especially those that have become resistant to current treatments. The lab also aims to create new proteins that can assist in drug binding and nutrient transport, contributing to advancements in therapeutic developments.